Asia
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
BioSpace recently spoke with Yoav Kimchy, founder and chief technology officer of Check-Cap, a company developing the C-Scan® system to detect precancerous polyps.
Early data from a Phase III study for COVID-19 shows significant promise with its combo therapy reduced death and hospitalization in trial patients at high risk of progression by 78%.
The current continues as investment dollars flow into the life sciences. Here’s an overview who is catching the drift this week.
It was another busy week in clinical trial news. Here’s a look.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Junshi Biosciences announced that the Phase III clinical trial it is conducting alongside Coherus BioSciences on a potential non-small cell lung cancer drug shows positive preliminary results.
Global biopharma and life sciences companies provide updates to their businesses and pipelines.
In the past few weeks, China reminded the world that it is, first and foremost, a Communist nation. The recent crackdowns on the high-tech and education industries make some wonder what other changes will be next.
In a patent infringement lawsuit filed against Eli Lilly, Teva Pharmaceuticals won three and lost six patents. The patent lawsuit was over Teva’s Ajovy (fremanezumab-vfrm) to prevent migraines.
PRESS RELEASES